
Results
2
2 companies
Kuros Biosciences
Market Cap: CHF 893.2m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.80
7D
-11.4%
1Y
4.0%
Cosmo
Market Cap: CHF 1.5b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 93.50
7D
-7.8%
1Y
101.1%